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SUMMARY
Inertial cavitation inducing ultrasound-mediated microbubble treatments can produce resolution of vasospasm and restoration of distal arterial flow after peripheral artery injury. Resolution of catheterinduced vasospasm is likely to be nitric oxide-mediated because improvements in stenosis diameter and downstream blood flow were blunted following pretreatment with L-NAME. The potential for clinical applicability of this therapy is significant because: 1) microbubbles can be delivered systemically into the site of injury enabling relatively high local concentration; 2) targeted transcutaneous ultrasound delivery is achievable due to the proximity of vessels; and 3) microbubbles and diagnostic ultrasound system Infants and children with heart disease often undergo multiple CC procedures, and are at higher risk for catheter-induced vasospasm (CIV) and thrombosis.
Moreover, infants have an increased incidence of thromboembolism (1) . Up to 20% of thrombotic events occur in the femoral vessels (1) (2) (3) (4) and are associated with larger arterial access points (5-7) and longer procedure times. These factors may be compounded by small body size, polycythemia, and low cardiac output in sick infants (6, 8) . CIV and loss of femoral pulse after CC contributes to prolonged hospital stay, increased need for medical and/or surgical interventions, and difficulty with future vascular access. Despite technological improvements such as the use of indwelling arterial sheaths for a shorter duration (9) , smaller balloon/catheter profiles (10, 11) , and systemic heparinization (12) , complications of CC-related vascular injury continue to occur.
Ultrasound (US) has been investigated as an adjunct to pharmacologic thrombolysis, as well as an independent treatment for vascular thrombosis (13) (14) (15) (16) . Figure 1 shows an example of angiographic lumen size of the The angiographic lumen size of the femoral artery (white arrows) (from the site of injury to the popliteal artery) was measured before and after randomized treatments. The degree of CIV was similar in the pigs pre-treated with L-NAME (B). CIV ¼ catheter-induced vasospasm; L-NAME ¼ N (u)-nitro-L-arginine methyl ester; MB ¼ microbubble; US ¼ ultrasound.
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Noninvasive Treatment of Vascular Injury and Spasm 751 femoral artery at baseline, with creation of CIV, and after randomized US and MB treatment (in the presence and absence of L-NAME). Figure 2 shows the changes in a cross-section of the femoral lumen, and the popliteal Doppler at baseline, immediately after injury, and after diagnostic US þ MB treatment. (A to C) The Doppler peak velocity (Vmax) and velocity time integral (VTI) in the popliteal artery were measured before and after randomized treatments. The injured femoral artery was imaged as well.
J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 2 , N O . 6 , 2 0 1 7

Noninvasive Treatment of Vascular Injury and Spasm
D E C E M B E R 2 0 1 7 : 7 4 8 -5 6
752
The 3-level regression analysis of outcomes relative to animal, treatment type, and pre-versus post-treatment status is summarized in Table 2 .
The model for angiographic stenosis percentage was strong, and revealed effects attributable to both type of treatment and pre-versus post-treatment status, but negligible effects attributable to the animal. Although significant differences were observed before and after treatment, the models for popliteal Vmax and VTI were weaker. Further analysis focused on angiographic outcome with the various treatments; these are shown in Table 3 Values are mean AE SD.
DBP ¼ diastolic blood pressure; HR ¼ heart rate; SBP ¼ systolic blood pressure.
before and after the needle injury (before randomized treatment) in the L-NAME pre-treated groups were not different than the three groups that were not pre-treated with L-NAME (Figure 4) , indicating no direct effect of L-NAME alone on vessel diameters or flow changes. 
Values are mean AE SD.
L-NAME ¼ N (u)-nitro-L-arginine methyl ester; MB ¼ microbubble; US ¼ ultrasound.
FIGURE 4 Angiographic and Doppler Changes in L-NAME Group Versus Other Groups
Changes in angiographic diameters and Doppler flow parameters before and after needle injury (pre-treatment) in the L-NAME group pigs versus the other groups not pre-treated with L-NAME (combined for the sake of comparison). Note the percentage change in angiographic diameter, VTI, and Vmax is not different between the groups. Abbreviations as in Figures 1 and 2 .
Furthermore, transcutaneous low-frequency US energy alone has been shown to have vasodilatory effects mediated by an NO-dependent mechanism (27) . Resolution of CIV with US and MB therapy in our model is also likely to be NO-mediated because the improvement in stenosis diameter and downstream popliteal blood flow was blunted after pre-treatment with L-NAME, an inhibitor of nitric oxide synthase 
